NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.

New England Journal of Medicine Interviews by NEJM Group

Aug 19, 202613:08Religion & Spirituality

Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R...

Related Episodes

Continue listening to more episodes from New England Journal of Medicine Interviews.

NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.

Sep 16, 2026 - 9:23

Dhruv Khullar is an associate professor of population health sciences and of medicine at Weill Cornell Me...

NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.

Sep 9, 2026 - 11:35

Elizabeth Kaplan is a clinical instructor and the director of health care access at the Center for Health...

NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.

Sep 2, 2026 - 11:53

Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University Scho...

NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.

Aug 12, 2026 - 8:55

Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of...

NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.

Aug 5, 2026 - 11:14

Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute...

NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.

Jul 29, 2026 - 14:12

Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Reg...

NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.

Jul 22, 2026 - 8:40

Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center fo...

NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care.

Jul 15, 2026 - 8:05

Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the B...